EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization

Emilia Stellacci iD, Lucia Ziccardi iD, Alessandro Bruselles iD, Carmen Dell'Aquila iD, Luca Mignini iD, Marcello Niceta iD, Luigi Chiriatti iD, Mattia Carvetta iD, Erika Zara iD, Alessandro Leone iD, Serena Cecchetti iD, Simona Coppola iD und 3 weitere

International Journal of Molecular Sciences · 03.03.2026 · 27 (5) · 2368

DOI: 10.3390/ijms27052368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.03.2026. Verfasst von Emilia Stellacci und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, ADP-Ribosylation Factors, Mutation. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istituto Superiore di Sanità, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinitis pigmentosa (RP) comprises a heterogeneous group of inherited retinal dystrophies characterized by the progressive degeneration of photoreceptors, leading to night blindness and gradual loss of peripheral vision. RP is characterized by a substantial genetic heterogeneity, with more than 85 genes implicated across autosomal dominant, autosomal recessive, and X-linked inheritance patterns. Recent studies have identified mutations in the ARL3 gene as a causative factor in both syndromic and non-syndromic forms of RP, including autosomal dominant and recessive cases. ARL3 encodes a small GTPase that plays a crucial role in intracellular trafficking, particularly within photoreceptors. This process is critical for maintaining ciliary function and phototransduction. Here, we investigate the pathogenic mechanisms of the ARL3 c.199G>C (p.Asp67His) variant identified in individuals from a four-generation family. We show that mutant ARL3 disrupts normal protein expression and affects ciliogenesis. Clinically affected individuals showed a non-syndromic retinal degenerative RP phenotype, with marked intrafamilial heterogeneity, ranging from extensive retinal atrophy to the absence of clinical manifestation, independent of age. This report highlights the incomplete penetrance and variable expressivity associated with the ARL3 variant and emphasizes the value of combining molecular diagnostics with functional validation to expedite molecular diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinitis PigmentosaADP-Ribosylation FactorsMutationHumansPedigreeFemaleHeterozygotePhenotype

Stichwörter der Autor:innen

ARL3ciliopathiesfunctional validationretinal dystrophyretinitis pigmentosa

Substanzen

ADP-Ribosylation FactorsARL3 protein, human

Autor:innen und Institutionen

  • Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • IRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy.
  • Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Via De Sanctis 1, 86100 Campobasso, Italy.
  • Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, Viale di San Paolo 15, 00146 Rome, Italy.
  • Department of Biochemical Sciences "Alessandro Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.
  • CNMR, Istituto Superiore di Sanità, 00161 Rome, Italy.

ORCID-Profile: Emilia Stellacci, Lucia Ziccardi, Alessandro Bruselles, Carmen Dell'Aquila, Luca Mignini, Marcello Niceta, Luigi Chiriatti, Mattia Carvetta, Erika Zara, Alessandro Leone, Serena Cecchetti, Simona Coppola, Marco Tartaglia

Förderung

  • Istituto Superiore di Sanità
  • Italian Ministry of Health

Zitieren

APA

Stellacci, E., Ziccardi, L., Bruselles, A., Dell'Aquila, C., Mignini, L., Niceta, M., Chiriatti, L., Carvetta, M., Zara, E., Leone, A., Cecchetti, S., Coppola, S., Parisi, V., Tartaglia, M., & Cordeddu, V. (2026). A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization. International Journal of Molecular Sciences, 27(5), 2368. https://doi.org/10.3390/ijms27052368

Vancouver

Stellacci E, Ziccardi L, Bruselles A, Dell'Aquila C, Mignini L, Niceta M, et al. A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization. International Journal of Molecular Sciences. 2026;27(5):2368. doi:10.3390/ijms27052368

BibTeX
@article{Stellacci2026,
  author = {Stellacci, Emilia and Ziccardi, Lucia and Bruselles, Alessandro and Dell'Aquila, Carmen and Mignini, Luca and Niceta, Marcello and Chiriatti, Luigi and Carvetta, Mattia and Zara, Erika and Leone, Alessandro and Cecchetti, Serena and Coppola, Simona and Parisi, Vincenzo and Tartaglia, Marco and Cordeddu, Viviana},
  title = {A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2368},
  doi = {10.3390/ijms27052368}
}
Kostenlos starten →